A detailed history of Investors Research Corp transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Investors Research Corp holds 45,794 shares of TAK stock, worth $634,246. This represents 0.14% of its overall portfolio holdings.

Number of Shares
45,794
Previous 45,794 -0.0%
Holding current value
$634,246
Previous $636,000 6.92%
% of portfolio
0.14%
Previous 0.15%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$13.89 - $15.04 $27,946 - $30,260
-2,012 Reduced 4.21%
45,794 $636,000
Q4 2023

Jan 30, 2024

SELL
$13.36 - $15.43 $4,181 - $4,829
-313 Reduced 0.65%
47,806 $682,000
Q2 2023

Aug 14, 2023

SELL
$15.57 - $17.11 $31,140 - $34,220
-2,000 Reduced 3.99%
48,119 $755,000
Q4 2022

Feb 06, 2023

SELL
$12.42 - $15.62 $2,484 - $3,124
-200 Reduced 0.4%
50,119 $782,000
Q2 2022

Jul 21, 2022

BUY
$13.12 - $15.03 $45,264 - $51,853
3,450 Added 7.36%
50,319 $706,000
Q1 2022

Apr 13, 2022

BUY
$13.54 - $15.35 $174,666 - $198,015
12,900 Added 37.98%
46,869 $671,000
Q4 2021

Jan 27, 2022

BUY
$13.17 - $16.4 $131,739 - $164,049
10,003 Added 41.74%
33,969 $463,000
Q1 2021

Apr 28, 2021

SELL
$16.71 - $19.9 $17,963 - $21,392
-1,075 Reduced 4.29%
23,966 $438,000
Q4 2020

Jan 21, 2021

BUY
$15.39 - $18.97 $6,925 - $8,536
450 Added 1.83%
25,041 $456,000
Q3 2020

Oct 20, 2020

BUY
$17.1 - $19.19 $402,705 - $451,924
23,550 Added 2262.25%
24,591 $439,000
Q1 2019

Apr 23, 2019

BUY
$16.7 - $21.52 $17,384 - $22,402
1,041 New
1,041 $21,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Investors Research Corp Portfolio

Follow Investors Research Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

News

Stay updated on Investors Research Corp with notifications on news.